ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,53
-0,68%
Dow Jones
40 211,72
0,53%
DAX
18 494,88
-0,57%
Brent Oil
83,65
-0,82%
Bitcoin
62 684,79
-3,34%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioPlus Acquisition Corporation (BIOS)

  7. BioPlus Acquisition Corporation (BIOS) Actualités

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateHeureSourceTitreSymboleSociété
07/08/201922h54Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BIOSBioPlus Acquisition Corporation
07/08/201914h24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
07/08/201914h00Business WireOption Care and BioScrip Complete Merger to Form Option Care HealthNASDAQ:BIOSBioPlus Acquisition Corporation
02/08/201918h40GlobeNewswire Inc.BioScrip Announces Shareholder Approval of Merger with Option CareNASDAQ:BIOSBioPlus Acquisition Corporation
31/07/201922h41Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
30/07/201922h58Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BIOSBioPlus Acquisition Corporation
30/07/201914h00GlobeNewswire Inc.BioScrip Reports Second Quarter 2019 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
22/07/201915h00GlobeNewswire Inc.Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transa...NASDAQ:BIOSBioPlus Acquisition Corporation
10/07/201923h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIOSBioPlus Acquisition Corporation
26/06/201922h12Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:BIOSBioPlus Acquisition Corporation
24/06/201915h29GlobeNewswire Inc.LogistiCare Announces Leadership TransitionNASDAQ:BIOSBioPlus Acquisition Corporation
13/06/201915h00GlobeNewswire Inc.Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Ca...NASDAQ:BIOSBioPlus Acquisition Corporation
10/06/201917h47GlobeNewswire Inc.RLH Corporation Announces Changes to Its Board of DirectorsNASDAQ:BIOSBioPlus Acquisition Corporation
06/06/201914h57Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:BIOSBioPlus Acquisition Corporation
30/05/201922h32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BIOSBioPlus Acquisition Corporation
21/05/201915h00GlobeNewswire Inc.BioScrip to Participate in Upcoming Investor ConferencesNASDAQ:BIOSBioPlus Acquisition Corporation
02/05/201913h00GlobeNewswire Inc.BioScrip Reports First Quarter 2019 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
30/04/201923h09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
30/04/201914h17Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:BIOSBioPlus Acquisition Corporation
23/04/201915h00GlobeNewswire Inc.BioScrip, Inc. Provides Merger UpdateNASDAQ:BIOSBioPlus Acquisition Corporation
15/03/201912h22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
15/03/201912h01GlobeNewswire Inc.BioScrip Reports Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
15/03/201912h00GlobeNewswire Inc.Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to MergeNASDAQ:BIOSBioPlus Acquisition Corporation
14/03/201903h11GlobeNewswire Inc.BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
25/02/201920h00GlobeNewswire Inc.BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
15/02/201912h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
03/01/201915h00GlobeNewswire Inc.BioScrip to Present at the 37th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
26/11/201822h30GlobeNewswire Inc.BioScrip to Host Analyst and Investor DayNASDAQ:BIOSBioPlus Acquisition Corporation
20/11/201815h00GlobeNewswire Inc.BioScrip to Present at the Bank of America Merrill Lynch 2018 Leveraged Finance ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
09/11/201822h22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS

Dernières Valeurs Consultées

NASDAQ
SCOBU
ScION Tech Growth II
BIT
P1QLT4
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés